LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 204 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,120,563 | -73.8% | 18,701 | -68.5% | 0.00% | -71.4% |
Q2 2023 | $4,284,686 | +647.9% | 59,427 | +663.1% | 0.01% | +600.0% |
Q1 2023 | $572,885 | -70.4% | 7,788 | -73.1% | 0.00% | -66.7% |
Q4 2022 | $1,935,997 | +745.4% | 28,982 | +987.1% | 0.00% | – |
Q3 2022 | $229,000 | +32.4% | 2,666 | +37.3% | 0.00% | – |
Q2 2022 | $173,000 | -87.9% | 1,942 | -84.8% | 0.00% | -100.0% |
Q1 2022 | $1,433,000 | -49.3% | 12,743 | -30.4% | 0.00% | -33.3% |
Q4 2021 | $2,826,000 | – | 18,298 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |